IQVIA

Digital

Nine for 2022: innovation and opportunities in healthcare

In the second part of our examination of issues that will shape the course of 2022, we’ll update the ongoing impacts of the pandemic, which have, as they did in 2021, a pervasive effect on

R&D

Young attractive female scientist holding a red transparent pill with futuristic scientific air interface with chemical formulas and research data in the foreground

Drug development and working with specialised Rare Disease n...

There are currently an estimated 300 million people living with one or more Rare Diseases across the world.

Sales & Marketing

Launch excellence: escaping the complexity trap

IQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex world.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

The power of R&D collaborations to improve outcomes in rare ...

Far more common than initially thought, rare disease treatments remain far too scarce.

News

Achieving patient centricity in a digital health world

Around 250 digital health apps are launching every day, says...

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is curren

Views & Analysis

Surprise pandemic lessons for pharma

Ask people in most western nations to think back to 2019 and consider what they would have said then about the potential impact of a pandemic on their everyday lives and my guess is that th